Skip to content
European Centre for Disease Prevention and Control (ECDC) - Logo
The European Union Drugs Agency (EUDA) - Logo

References

  • (ECDC, 2024). European Centre for Disease Prevention and Control. Monitoring of the responses to the hepatitis B and C epidemics in EU/EEA countries, 2023. Stockholm: ECDC; 2024. Available at: https://www.ecdc.europa.eu/sites/default/files/documents/Monitoring-responses-hepatitis-B-C-epidemics.pdf
  • (EMCDDA, 2022). European Monitoring Centre for Drugs and Drug Addiction (2022), Prison and drugs in Europe: current and future challenges. Publications Office of the European Union, Luxembourg. Available at https://www.euda.europa.eu/publications/insights/prison-and-drugs-in-europe_en
  • (EUDA, 2024). EUDA, Statistical Bulletin 2024 — drug use and prison, 2024. Available at https://www.euda.europa.eu/data/stats2024/dup_en
  • (Eurostat, 2021). Eurostat, ‘EU prisons in 2021: populations and overcrowding’, 12 May 2023. Available at: https://ec.europa.eu/eurostat/web/products-eurostat-news/w/ddn-20230512-2
  • (Eurostat, 2024). Eurostat, Prison statistics, data extracted April 2024. Available at: https://ec.europa.eu/eurostat/statistics-explained/index.php?title=Prison_statistics
  • (Giusti A, 2020). Giusti A, Nkhoma K, Petrus R, Petersen I, Gwyther L, Farrant L, et al. The empirical evidence underpinning the concept and practice of person-centred care for serious illness: a systematic review. BMJ Glob Health. 2020 Dec;5(12):e003330. doi: 10.1136/bmjgh-2020-003330.
  • (Hajarizadeh Bl, 2021). Hajarizadeh B, Grebely J, Byrne M, Marks P, Amin J, McManus H, et al.; SToP-C study group. Evaluation of hepatitis C treatment-as-prevention within Australian prisons (SToP-C): a prospective cohort study. Lancet Gastroenterol Hepatol. 2021 Jul;6(7):533-546. doi: 10.1016/S2468-1253(21)00077-7.
  • (Kwon JA, 2021). Kwon JA, Chambers GM, Luciani F, Zhang L, Kinathil S, Kim D, et al. Hepatitis C treatment strategies in prisons: A cost-effectiveness analysis. PLoS One. 2021 Feb 11;16(2):e0245896. doi: 10.1371/journal.pone.0245896.
  • (Marshal T, 2001). Marshall T, Simpson S, Stevens A. Health care needs assessment in prisons: a toolkit. J Public Health Med. 2001 Sep;23(3):198-204. doi: 10.1093/pubmed/23.3.198.
  • (Nakitanda AO., 2020). Nakitanda AO, Montanari L, Tavoschi L, Mozalevskis A, Duffell E. Hepatitis C virus infection in EU/EEA and United Kingdom prisons: opportunities and challenges for action. BMC Public Health. 2020 Nov 9;20(1):1670. doi: 10.1186/s12889-020-09515-6.
  • (Nakitanda AO, 2021). Nakitanda AO, Montanari L, Tavoschi L, Mozalevskis A, Duffell E. Hepatitis B virus infection in EU/EEA and United Kingdom prisons: a descriptive analysis. Epidemiol Infect. 2021 Jan 25;149:e59. doi: 10.1017/S0950268821000169.
  • (UKHSA, 2015). UK Health Security Agency. O’Moore É. ‘The community dividend: why improving prisoner health is essential for public health’, 2015. Available at https://ukhsa.blog.gov.uk/2015/07/06/the-community-dividend-why-improving-prisoner-health-is-essential-for-public-health/
  • (WHO, 2024). World Health Organization (WHO). 2024. Social determinants of health. Available at: https://www.who.int/health-topics/social-determinants-of-health#tab=tab_1